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Abstract
Background:  Leptospirosis is an emerging infectious disease. The differential diagnosis of
leptospirosis is difficult due to the varied and often "flu like" symptoms which may result in a missed
or delayed diagnosis. There are over 230 known serovars in the genus Leptospira. Confirmatory
serological diagnosis of leptospirosis is usually made using the microscopic agglutination test (MAT)
which relies on the use of live cultures as the source of antigen, often performed using a panel of
antigens representative of local serovars. Other techniques, such as the enzyme linked
immunosorbent assay (ELISA) and slide agglutination test (SAT), can detect different classes of
antibody but may be subject to false positive reactions and require confirmation of these results by
the MAT.
Methods: The polymerase chain reaction (PCR) has been used to detect a large number of
microorganisms, including those of clinical significance. The sensitivity of PCR often precludes the
need for isolation and culture, thus making it ideal for the rapid detection of organisms involved in
acute infections. We employed real-time (quantitative) PCR using TaqMan chemistry to detect
leptospires in clinical and environmental samples.
Results and Conclusions: The PCR assay can be applied to either blood or urine samples and
does not rely on the isolation and culture of the organism. Capability exists for automation and high
throughput testing in a clinical laboratory. It is specific for Leptospira and may discriminate
pathogenic and non-pathogenic species. The limit of detection is as low as two cells.
Background
Leptospirosis is an emerging infectious disease [1]. Lept-
ospira spp. are endemic to feral and domestic animals that
may serve as reservoirs, with rats and rodents recognised
as the most important sources [2,3]. Human infections re-
sult from contact with contaminated soil, vegetation or
water, or with the body fluids of infected animals. The ge-
nus Leptospira comprises both pathogenic and non-patho-
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genic species: L. interrogans, L. borgpetersenii, L. weilii, L.
noguchii, L. meyeri, L. fainei, L. alexanderi, L. santarosai, L.
kirschneri, L. inadai; L. biflexa, and L. wolbachii[1]. There is
some controversy about the classification or pathogenici-
ty of some members within species such as L. meyeri and
L. inadai[2,4,5].
The differential diagnosis of leptospirosis is difficult due
to the varied and often "flu like" symptoms which may re-
sult in a missed or delayed diagnosis [6]. For example, pa-
tients presenting with severe fever and haemorrhage have
symptoms which are difficult to distinguish from viral
haemorrhagic fever [7].
There are over 230 known serovars in the genus Lept-
ospira[2]. Confirmatory serological diagnosis of lept-
ospirosis is usually made using the microscopic
agglutination test (MAT) which is able to detect specific
antibody produced against the infecting leptospiral or-
ganism [2]. The MAT relies on the use of live cultures as
the source of antigen, often performed using a panel of
antigens representative of local serovars. A specific anti-
body response detectable by the MAT generally occurs at
around 8–10 days after onset of the illness [6]. The MAT
is generally performed by reference laboratories due to the
inherent safety risks of handling cultures of live leptospi-
ral organisms, the high cost of commercial media, and the
need for ongoing maintenance of representative serovars
or serogroups. Other techniques, such as the enzyme
linked immunosorbent assay (ELISA) and slide agglutina-
tion test (SAT), can detect different classes of antibody but
may be subject to false positive reactions and require con-
firmation of these results by the MAT [2].
Isolation of leptospires from human specimens is possi-
ble for limited periods in the course of the infection. This
may be due to limited survival of the organism in the col-
lected primary tissue or body fluid sample, immune sys-
tem responses, or exposure to administered antibiotics
[6]. Culture may take up to eight weeks and must be ex-
amined weekly. In the acute phase, which lasts up to
about 10 days, leptospires may be cultured from the
blood or cerebrospinal fluid (CSF), [2].
The polymerase chain reaction (PCR) has been used to de-
tect a large number of microorganisms, including those of
clinical significance [8–12]. The sensitivity of PCR often
precludes the need for isolation and culture, thus making
it ideal for the rapid detection of organisms involved in
acute infections. Moreover, using real-time PCR, it is pos-
sible to quantify the amount of template and therefore the
number of target organisms. Such quantitation can be
achieved using a number of approaches, for example em-
ploying TaqMan chemistry [13].
Attempts have been made to design PCR primers specifi-
cally for Leptospira spp. as reviewed by Levett [1]. It has
been difficult to identify all pathogenic species and, in
some instances, to discriminate between non-pathogenic
and pathogenic species. Although Woo et al., [14,15] have
employed TaqMan fluorogenic probes on leptospires, this
non-clinically directed research concentrated on the use of
TaqMan probes for the differentiation and identification
of Leptospira species using pure isolates obtained from a
reference culture collection.
In this paper, we report on the development of real-time
detection of Leptospira spp. using a TaqMan fluorogenic
probe. The assay is sensitive and appears able to differen-
tiate between pathogenic and non-pathogenic species
with highly sensitive limits of detection on clinical sam-
ples and without the need for prior isolation and culture.
Materials and Methods
We have received appropriate ethics approval for this
work and have complied with the Helsinki declaration.
DNA preparation
Genomic DNA from non-leptospiral bacterial strains (Ta-
ble 1) was extracted as described in [16]. Total DNA from
human serum (200 µl) and urine (200 µl) was prepared
using QIAamp DNA Mini Kits (QIAGEN, Australia) ac-
cording to the manufacturer's instructions.
Collection and testing of human sera
Single serum samples were from 66 patients with clinical-
ly suspected leptospirosis or from "at risk" occupations or
activities, for example persons in industries associated
with animal contact and agricultural workers [17]. These
sera were tested by combinations of polymerase chain re-
action (PCR), microscopic agglutination test (MAT) and a
commercially available anti-IgM ELISA (Pan Bio Pty Ltd,
Brisbane, Australia). Blood culture was conducted using
2–5 drops of whole blood placed into Ellinghausen Mc-
Cullough Johnson Harris medium (EMJH) solidified with
1.5% agarose and incubated at 37°C for up to seven
weeks.
Patient serum samples tested by MAT had a starting dilu-
tion of 1:50 and a diagnostic result (indicative of current
infection) declared where there was a fourfold change of
titre between acute and convalescent sera or a titre of 400
or greater was found with a single specimen. A positive
ELISA was confirmed by the MAT [2].
All serum samples were subjected to PCR. Fifty-two of the
serum samples were subjected to ELISA and 40 of the pa-
tients had blood culture requested by a clinician. Forty-
nine of the samples were subjected to MAT where there
was sufficient serum and/or a positive ELISA result.BMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/13
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Bacterial strains
Bacterial strains used in this study other than members of
the genus Leptospira, are shown in Table 1. Leptospira
strains were from the WHO/FAO/OIE Collaborating Cen-
tre collection and are given in Table 2. Representatives of
available non-pathogenic and pathogenic Leptospira spe-
cies as defined by Yasuda et al. [18] were included in the
study. The most commonly reported representative non-
pathogenic, free living strain, L. biflexa serovar patoc strain
Patoc 1, was included [2,19,1]. All cultures were grown in
EMJH broth (Difco Laboratories, Detroit, Michigan) and
maintained by weekly subculture into fresh medium. Cul-
tures used were grown up to seven days at 30°C to station-
ary phase to a density of approximately 2 ×  108 cells per
ml.
Design of TaqMan probes and PCR primers
The primers and probes were designed from alignments of
available Leptospira spp. 16S rDNA partial sequences ob-
tained from the GenBank nucleotide sequence database
(data not shown). The program used was Primer Express™
(Perkin-Elmer, Applied Biosystems, USA). The ability of
the primers and probe to identify leptospiral sequences
was initially assessed using the BLAST program [20]
against the National Center for Biotechnology Informa-
tion (NCBI) sequence database. The primers were synthe-
sized by Geneworks Pty. Ltd., Australia and the probe by
Pacific Oligos Pty Ltd, Australia.
The PCR primers Lepto F (5'171 CCCGCGTCCGATTAG 3')
and Lepto R (5'258 TCCATTGTGGCCGRA/GACAC3') were
located between the positions 171 and 258 of the rrs
(16S) gene with an expected product size of 87 bp prod-
uct. The probe [5'205(FAM)
CTCACCAAGGCGACGATCGGTAGC228 3' (TAMRA)]
had the fluorescent reporter dye, 6-carboxy-fluorescein
(FAM) located at the 5' end of the probe and the quencher
6-carboxy-tetramethyl-rhodamine (TAMRA) located at
the 3' end.
PCR conditions
For all PCRs, 5 µl of DNA was added to the 45 µl TaqMan
Universal PCR Mastermix Mix (Applied Biosystems, Fos-
ter City, CA) part number 4304437, providing final con-
centrations of 3 pmol/µl of each primer and 2 pmol/µl of
the FAM-TAMRA labelled probe. A no template control
(NTC) that contained all the above reagents was also in-
cluded to detect the presence of contaminating DNA. Am-
plification and fluorescence detection was conducted in
an ABI Prism 7700 sequence detector (Perkin – Elmer, Ap-
plied Biosystems, USA) with a program of 40 cycles, each
cycle consisting of 95°C for 15 seconds and 60°C for one
minute. A negative result was assigned where no amplifi-
cation occurred, i.e. the threshold cycle (Ct) value was
greater than 40 cycles.
DNA template at dilutions of 1:100, 1:1000, 1:2000,
1:4000 and 1:8000 for non-leptospiral cells and leptospi-
ral culture dilutions from 108 to 100 were prepared using
pH 7.4 phosphate buffered saline solution [21]. The
number of cells in culture was determined using a Petroff
Hauser bacterial counting chamber [2] and adjusted to an
initial concentration of 108 cells per ml. For DNA extrac-
tion of non-leptospiral cells, a single colony was picked
(except in the case of Borrelia burdorferi where a 200 µl al-
iquot of heat-killed whole antigen was used) then mixed
in 500 µl of sterile distilled water. Analyses of non-lept-
ospiral samples were run in triplicate and leptospiral cells
in duplicate.
Detection of PCR inhibitors
Blood (negative by MAT for leptospirosis antibodies) was
collected from a single source using each of the collection
tube systems listed in Table 3. Serum or plasma was then
prepared from these blood samples and 200 µl of each of
these samples was then extracted using a QIAamp Mini Kit
Table 1: List of bacterial strains used for TaqMan PCR
Strain Source
Escherichia coli NCTC 10418
Yersinia enterocolitica ATCC 9610
Shigella sonnei PHM 205
Escherichia coli NCTC 9001
Enterobacter aerogenes NCTC 10006
Pseudomonas aeruginosa NCTC 10332
Citrobacter freundii NCTC 9750
Pseudomonas fluorescens NCTC 10038
Proteus vulgaris NCTC 4635
Klebsiella pneumoniae PHM 15
Alcaligenes faecalis ATCC 15246
Salmonella salford IMVS 1710
Vibrio cholerae ACM 3983
Pasteurella multocida UQ
Salmonella dublin PHM 82
Borrelia burgdorferi B31
Staphylococcus epidermis NCTC 6513
Staphyloccocus aureus NCTC 6513
Bacillus cereus PHM3
Enterococcus faecalis NCTC 775
Listeria seeligeri PHM20
Listeria monocytogenes PHM19
NCTC: National Collection of Type Cultures, Collindale, USA ATCC: 
American Type Culture Collection, USA PHM: Public Health Microbi-
ology, Brisbane, Australia IMVS: Institute of Medical and Veterinary 
Science, Adelaide, Australia ACM: Australian Culture Microorganisms, 
Brisbane, Australia UQ: University of Queensland, Brisbane, Australia 
ICPMR: Institute of Clinical Pathology and Medical Research, West-
mead, NSW, AustraliaBMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/13
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and the DNA eluted with 200 µl of elution buffer. A 5 µl
volume of these DNA extracts was added to individual
PCR reaction tubes containing a standard amount of DNA
corresponding to a known Ct value. The test samples were
run in triplicate.
Results
Specificity and sensitivity of the PCR assay
To assess the specificity of the primers and probe, 29 lept-
ospiral strains (Table 2) and 22 other bacterial pathogens
(Table 1) were subjected to PCR. A detectable product was
observed for all the 23 pathogenic leptospiral strains. Oth-
er bacterial strains and non-pathogenic leptospiral strains
did not yield amplification products.
The sensitivity of the assay was evaluated using DNA ex-
tracted from 108–100 tenfold dilutions of two Leptospira
reference cultures L. borgpeterseni serovar hardjo and L. in-
terrogans serovar pomona. A minimum detection limit of
approximately two cells was established in the PCR reac-
tion mixture.
Table 2: Leptospiral serovars used for TaqMan PCR
Serogroup Serovar Strain Species
Pathogenic
Celledoni celledoni Celledoni L. weilii
Bataviae bataviae Swart L. interrogans
Canicola canicola Hond Utrecht IV L. interrogans
Icterohaemorrhagiaea copenhageni M20 L. interrogans
Javanica javanica Veldrat Batavia 46 L. borgpeterseni
Ballum ballum Mus 127 L. borgpeterseni
Hebdomadis kremastos Kremastos L. interrogans
Sejroe hardjo Hardjobovis L. borgpeterseni
Grippotyphosa grippotyphosa Moska V L. interrogans
Djasiman djasiman Djasiman L. interrogans
Tarassovi tarassovi Perepelitsin L. borgpeterseni
Australis australis Ballico L. interrogans
Sejroe medanensis Hond HC L. interrogans
Panama panama CZ214 K L. noguchi
Pyrogenes robinsoni Robinson L. interrogans
Autumnalis bulgarica Nicolaevo L. kirschneri
Szwajizak szwajizak Mini L. interrogans
Pomona pomona Pomona L. interrogans
Hurstbridge hurstbridge BUT 6 L. fainei
Pyrogenes zanoni Zanoni L. interrogans
Cynopteri cynopteri 3522 C L. kirschneri
Shermani shermani 1342 K L. santarosai
Non-pathogenica
Semaranga patoc Patoc 1 L. biflexa
Codice codice CDC L. wolbachi
Andamana andaman CH11 L. biflexa
Leptonema illini 3055 Leptonema illini
Lyme lyme 10 L. inadai
Ranarum ranarum ICF L. meyeri
Pathogenicity controversial
Mini perameles Bandicoot 343 L. meyerib
-- F e r a l L. inadai-like
aAll species are non-pathogenic as reported by Yasuda et al. [5]b This species classification has been controversial as reported by Postic et al. [4]BMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/13
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Detection of leptospiral DNA in human clinical specimens
To assess the ability of the PCR to detect the presence of
leptospiral cells in human serum, 66 patients were tested
who had clinical symptoms consistent with leptospirosis
and/or were from "at risk" occupations or activities. Isola-
tion of leptospires, MAT and ELISA were not attempted on
all patients (see Materials and Methods for details).
For the 49 patients tested by MAT, 17 were positive with
titres ranging from 50 to 3200. Of the 17 samples which
tested positive, three were equivocal using ELISA and all
17 did not produce a product using PCR. Of the twenty
seven patients found negative using ELISA, and the 36
negative by culture, all were determined negative by PCR.
Four serum samples which tested negative using MAT did
produce a PCR product. Furthermore, these samples yield-
ed a positive result by culture. Three of these samples later
showed diagnostic rises by MAT (Table 4). Unfortunately
no serum for the fourth patient was available for MAT but
the isolate was preliminarily identified by MAT as equiva-
lent to L. interrogans serovar zanoni (Table 4).
Detection of Leptospira spp. in urine
To assess the ability of the PCR to detect the presence of
leptospiral cells in urine, serial tenfold dilutions of cells of
L. interrogans serovar icterohaemorrhagiae (with numbers
confirmed using a Petroff-Hauser counting chamber)
were mixed with urine from a leptospirosis-negative
source and tested in duplicate by PCR. The estimated limit
of detection was 10 cells. The results suggest an ability of
the PCR to detect leptospires in clinical urine samples but
this needs to be further evaluated.
Blood collection system inhibition
We tested representatives of a number of standard clinical
blood collection systems which contained chemical com-
ponents which may interfere with PCR. Only those collec-
tion systems (Table 3) containing lithium heparin
interfered with the PCR. Collection tubes containing lith-
ium heparin demonstrated mean Ct values of 23.97 and
21.7 compared to the expected value of 18.32.
Discussion
This report describes the development of a real-time PCR
assay employing a TaqMan probe for the detection and
quantitation of organisms belonging to the genus Lept-
ospira. The assay detected pathogenic Leptospira species,
but seemed not to detect non-pathogenic strains (see Ta-
ble 2), nor a number of commonly-occurring non-lept-
ospiral pathogens (see Table 1), including the spirochete
Borrelia burdorferi. There is some contention about wheth-
er L. meyeri and L. inadai are pathogenic [2,4]. We ob-
served an amplification product for L. meyeri serovar
perameles strain bandicoot 343, a strain considered by at
least one group to be pathogenic [4]. The amplification
product obtained for our strain Feral, an inadai species like
organism [5] but not L. inadai serovar lyme strain 10, a
non-pathogen, suggests the PCR detects some members
within this species but further evaluation of strain Feral
will need to be undertaken.
The ability of the PCR to distinguish between pathogenic
and non-pathogenic Leptospira species may be useful for
the testing of environmental samples but this will require
further evaluation. The non-pathogenic representative of
L. biflexa used in this study is the most commonly-de-
scribed environmental contaminant and frequently con-
fuses the identification of pathogenic strains from
environmental samples. Culture under specialized condi-
tions facilitates discrimination between L. biflexa and oth-
er pathogenic species, it is however possible the PCR
could provide an alternate or supporting role for identifi-
cation.
This PCR assay provides the potential to detect pathogenic
Leptospira spp. in a range of clinical specimens providing
for earlier diagnosis and unequivocal evidence of active
infection. As reported for the detection of meningococcal
cells [22], the PCR assay developed in this work will pro-
vide an enhanced capability for confirmation of cases
where early antibiotic treatment has precluded detection
by culture. Opportunity also exists for better postmortem
testing where samples are generally of poor quality and do
not lend themselves to culturing or serology.
The limit of detection of leptospires in urine was approx-
imately 10 cells and for serum approximately 2 cells. The
reason for the lower sensitivity in urine samples is not
clear, however, two possible reasons are that a component
in the urine sample was extracted with the DNA and inter-
fered with the PCR [2], or that extraction of DNA from
Table 3: List of sample collection tubes
Collection Tube Description TaqMan Result 
(Average Ct)
Lithium Heparin 23.40
EDTA, Liquid (K2) 18.50
Sodium Citrate 3.2 % 18.25
EDTA (Spray Coated), (K2) 18.37
Fluoride Oxalate 18.61
Clot activator 19.03
Plasma Separation Tube (PST), Lithium 
Heparin and Polymer Gel
21.79
Acid Citrate Dextrose (ACD) Solution A 18.35
Clot activator and Polymer gel 18.20BMC Infectious Diseases 2002, 2 http://www.biomedcentral.com/1471-2334/2/13
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cells in urine is not as efficient as that in serum. The assay
of Merien et al. [23] reported very similar detection levels
for seeded urine samples. Bal et al. [24] successfully de-
tected leptospires in patient urine by conventional PCR
analysis but recorded problems of reproducibility and
sensitivity with different extraction methods caused by the
presence of inhibitors. Further investigations of extraction
methods for urine will need to be undertaken to monitor
the impact of inhibitors.
Previously the diagnosis of leptospirosis has relied heavily
on the detection of antibodies using either ELISA or MAT.
In many cases, particularly in the early phase of infection,
the lack of antibodies in patient sera results in an inability
to confirm diagnosis. Patients presenting with clinical
symptoms suggestive of leptospirosis will have an oppor-
tunity for early detection on a single specimen and the
process has the potential to greatly enhance patient man-
agement through the timely commencement of medical
treatment.
Because real-time PCR enables the quantitative monitor-
ing of leptospiral cells, there exists the opportunity to
monitor treatment efficacy, in particular the use of chem-
otherapeutics. For example, patients in intensive care
management, where ineffective treatment is life-threaten-
ing, would greatly benefit from direct measurements of in-
fectious organisms.
The PCR assay developed in this study can be completed
in around 5 hours. This assay also lends itself to large-
scale analysis due to the availability of high-throughput
sequence detection systems.
The tube collection systems evaluation demonstrated that
lithium heparin may inhibit the PCR. The observed in-
crease in Ct value for the lithium heparin tubes suggests
that relevant controls need to be included.
The assay will have application in the human and veteri-
nary fields as both a research tool and supporting diagnos-
tic test.
Conclusions
We have developed a real-time PCR assay for the detection
of leptospires in clinical and environmental samples. This
method appears to discriminate pathogenic from non-
pathogenic strains and can detect as few as 2 cells in serum
and 10 cells in urine. The PCR method has a clear advan-
tage over other methods such as the microscopic aggluti-
nation test (MAT) which relies on the detection of
antibodies, the presence of which cannot be detected until
days after infection.
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